Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Siddharth M. Patel"'
Autor:
Siddharth M. Patel, Arman Qamar, Robert P. Giugliano, Petr Jarolim, Nicholas A. Marston, Jeong-Gun Park, Michael A. Blazing, Christopher P. Cannon, Eugene Braunwald, David A. Morrow
Publikováno v:
JAMA cardiology. 7(12)
ImportanceStudies have demonstrated an association between single measures of high-sensitivity troponin (hsTn) and future cardiovascular events in patients with chronic coronary syndromes. However, limited data exist regarding the association between
Autor:
Siddharth M, Patel, David D, Berg, Erin A, Bohula, Vivian M, Baird-Zars, Christopher F, Barnett, Gregory W, Barsness, Sunit-Preet, Chaudhry, Lori B, Daniels, Sean, van Diepen, Shahab, Ghafghazi, Michael J, Goldfarb, Jacob C, Jentzer, Jason N, Katz, Benjamin B, Kenigsberg, Patrick R, Lawler, P Elliot, Miller, Alexander I, Papolos, Jeong-Gun, Park, Brian J, Potter, Rajnish, Prasad, N Sarma V, Singam, Shashank S, Sinha, Michael A, Solomon, Jeffrey J, Teuteberg, David A, Morrow, A, Thomas
Publikováno v:
Circulation: Heart Failure. 16
Background: Algorithmic application of the 2019 Society of Cardiovascular Angiography and Intervention (SCAI) shock stages effectively stratifies mortality risk for patients with cardiogenic shock. However, clinician assessment of SCAI staging may di
Publikováno v:
Journal of the American College of Cardiology. 78:2144-2146
Autor:
Siddharth M Patel, Michael G Palazzolo, Sabina A Murphy, Elliot M Antman, Eugene Braunwald, Hans-Joachim Lanz, Gregory Y H Lip, Robert P Giugliano, Christian T Ruff
Publikováno v:
Patel, S M, Palazzolo, M G, Murphy, S A, Antman, E M, Braunwald, E, Lanz, H J, Lip, G Y H, Giugliano, R P & Ruff, C T 2022, ' Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial ', Europace, vol. 24, no. 11, pp. 1730-1738 . https://doi.org/10.1093/europace/euac082
Aims The Atrial fibrillation Better Care (ABC) pathway is endorsed by guidelines to improve care of patients with atrial fibrillation (AF). However, whether the benefit of ABC pathway-concordant care is consistent across anticoagulants remains unclea
Autor:
Siddharth M Patel, Christopher P Cannon, KyungAh Im, Michael A Blazing, Yale B Mitchel, Marc S Sabatine, Robert P Giugliano, Erin A Bohula
Publikováno v:
Circulation. 144
Introduction: Ezetimibe (EZE) added to statin further reduces LDL-C and CV events. Prior studies demonstrated large inter-individual variability in LDL-C reduction with statins. Whether similar variability exists with EZE has not been reported in a l
Publikováno v:
EuroIntervention
BACKGROUND: Bleeding is the principal safety concern of antithrombotic therapy and occurs frequently among patients with coronary artery disease (CAD). AIMS: We aimed to evaluate the prognostic impact of bleeding on mortality compared with that of my
Publikováno v:
Journal of the American College of Cardiology. 78(22)
Publikováno v:
Current Opinion in Cardiology. 34:721-727
Residual risk for atherosclerotic cardiovascular disease (ASCVD) persists even among patients with optimal low-density lipoprotein cholesterol (LDL-C) levels. Randomized trials attempting to modulate other lipids beyond LDL-C have failed to demonstra
Autor:
Stephen Kidd, Erica L. Goodrich, Benjamin M. Scirica, Siddharth M. Patel, Marc P. Bonaca, David A. Morrow
Publikováno v:
Vascular medicine (London, England). 24(2)
Autor:
Rohan V. Menon, Anna Kotsia, Dharam J. Kumbhani, Nagendra R. Pokala, Bavana V. Rangan, Jeffrey L. Hastings, Jerrold Grodin, George Christopoulos, Siddharth M. Patel, Subhash Banerjee, Michele Roesle, Emmanouil S. Brilakis, Shuaib M Abdullah, Georgios E. Christakopoulos
Publikováno v:
Catheterization and Cardiovascular Interventions. 87:34-40
Background As compared with bare metal stents, first-generation drug-eluting stents (DES) improved post-procedural outcomes in aortocoronary saphenous vein graft (SVG) lesions, but there is limited information on outcomes after use of second-generati